Free Malaysia Today Pfizer’s earnings boosted by Covid-19 products, lower expenses
The big US drugmaker raised its full-year profit forecast after easily topping analyst expectations.
The big US drugmaker raised its full-year profit forecast after easily topping analyst expectations.